Literature DB >> 34206629

Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring.

Qing Guo1, Yi Tang1, Ying Li1, Ziyuan Xu1, Di Zhang1, Jiangtao Liu1, Xin Wang1, Wei Xia1, Shunqing Xu1.   

Abstract

A perinatal high-salt (HS) diet was reported to elevate plasma triglycerides. This study aimed to investigate the hypothesis that a perinatal HS diet predisposed offspring to non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of abnormal lipid metabolism, and the possible mechanism. Female C57BL/6 mice were fed a control diet (0.5% NaCl) or HS diet (4% NaCl) during pregnancy and lactation and their offspring were sacrificed at weaning. The perinatal HS diet induced greater variation in fecal microbial beta-diversity (β-diversity) and increased bacteria abundance of Proteobacteria and Bacteroides. The gut microbiota dysbiosis promoted bile acid homeostasis disbalance, characterized by the accumulation of lithocholic acid (LCA) and deoxycholic acid (DCA) in feces. These alterations disturbed gut barrier by increasing the expression of tight junction protein (Tjp) and occludin (Ocln), and increased systemic lipopolysaccharide (LPS) levels and hepatic inflammatory cytokine secretion (TNF-α and IL-6) in the liver. The perinatal HS diet also inhibited hepatic expression of hepatic FXR signaling (CYP7A1 and FXR), thus triggering increased hepatic expression of pro-inflammatory cytokines (TNF-α and IL-6) and hepatic lipid metabolism-associated genes (SREBP-1c, FAS, ACC), leading to unique characteristics of NAFLD. In conclusion, a perinatal HS diet induced NAFLD in weanling mice offspring; the possible mechanism was related to increased bacteria abundance of Proteobacteria and Bacteroides, increased levels of LCA and DCA in feces, and increased expressions of hepatic FXR signaling.

Entities:  

Keywords:  bile acid; gut microbiota; hepatic inflammation; high-salt diet; non-alcoholic fatty liver disease

Year:  2021        PMID: 34206629     DOI: 10.3390/nu13072135

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  61 in total

1.  Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.

Authors:  Qiong Li; Meng Li; Fenghua Li; Wenjun Zhou; Yanqi Dang; Li Zhang; Guang Ji
Journal:  J Ethnopharmacol       Date:  2020-04-20       Impact factor: 4.360

2.  Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.

Authors:  Zhao-Xia Yang; Wei Shen; Hang Sun
Journal:  Hepatol Int       Date:  2010-08-12       Impact factor: 6.047

3.  Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.

Authors:  Prasant K Jena; Lili Sheng; Hui-Xin Liu; Karen M Kalanetra; Annie Mirsoian; William J Murphy; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

4.  Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.

Authors:  Huawei Zeng; Kate J Larson; Wen-Hsing Cheng; Michael R Bukowski; Bryan D Safratowich; Zhenhua Liu; Reza Hakkak
Journal:  J Nutr Biochem       Date:  2020-01-08       Impact factor: 6.048

5.  Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood.

Authors:  Xin Dai; Zixuan Guo; Danfeng Chen; Lu Li; Xueli Song; Tianyu Liu; Ge Jin; Yun Li; Yi Liu; Aihemaiti Ajiguli; Cheng Yang; Bangmao Wang; Hailong Cao
Journal:  Gut Microbes       Date:  2020-03-31

6.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Authors:  Jérôme Boursier; Olaf Mueller; Matthieu Barret; Mariana Machado; Lionel Fizanne; Felix Araujo-Perez; Cynthia D Guy; Patrick C Seed; John F Rawls; Lawrence A David; Gilles Hunault; Frédéric Oberti; Paul Calès; Anna Mae Diehl
Journal:  Hepatology       Date:  2016-01-13       Impact factor: 17.425

Review 7.  Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension.

Authors:  Yan-Ci Zhao; Guo-Jun Zhao; Ze Chen; Zhi-Gang She; Jingjing Cai; Hongliang Li
Journal:  Hypertension       Date:  2019-12-23       Impact factor: 10.190

8.  Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response.

Authors:  Susara Madduma Hewage; Suvira Prashar; Karmin O; Yaw L Siow
Journal:  Antioxidants (Basel)       Date:  2021-04-06

9.  Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice.

Authors:  Jingjuan Hu; Haihua Luo; Jieyan Wang; Wenli Tang; Junqi Lu; Shan Wu; Zhi Xiong; Guizhi Yang; Zhenguo Chen; Tian Lan; Hongwei Zhou; Jing Nie; Yong Jiang; Peng Chen
Journal:  Exp Mol Med       Date:  2017-08-25       Impact factor: 8.718

10.  (-)-Epicatechin and NADPH oxidase inhibitors prevent bile acid-induced Caco-2 monolayer permeabilization through ERK1/2 modulation.

Authors:  Ziwei Wang; M Corina Litterio; Michael Müller; David Vauzour; Patricia I Oteiza
Journal:  Redox Biol       Date:  2019-10-22       Impact factor: 11.799

View more
  2 in total

1.  Medicinal Formula Huazhi-Rougan Attenuates Non-Alcoholic Steatohepatitis Through Enhancing Fecal Bile Acid Excretion in Mice.

Authors:  Chunlin Li; Siyu Yu; Xiaoxiao Li; Ying Cao; Meng Li; Guang Ji; Li Zhang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

2.  Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022.

Authors:  Dan Long; Chenhan Mao; Xinyue Zhang; Yaxuan Liu; Xueli Shangguan; Menglong Zou; Ying Zhu; Xindong Wang
Journal:  Front Cardiovasc Med       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.